The therapeutic tumor model was performed to determine the whether the CD4+ and CD8+ T cell responses induced by HCA587 SLP immunization with AddaVax and CpG 2395 could translate into anti-tumor effect in vivo. The gene discussed is CD8A; the disease is neoplasm.